
|Videos|October 11, 2016
Atopic Dermatitis: Cost and Value
Advertisement
Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Jonathan Silverberg, MD, PhD, MPH; Ed Pezalla, MD, MPH; and Jeffrey D. Dunn, PharmD, MBA, provide insight on balancing the cost and benefit of treatments for atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
3
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
4
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
5

















































































































































































































